Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2000 Mar 14;97(6):2767-72.
doi: 10.1073/pnas.040570597.

Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement

Affiliations
Case Reports

Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement

V Ntziachristos et al. Proc Natl Acad Sci U S A. .

Abstract

We present quantitative optical images of human breast in vivo. The images were obtained by using near-infrared diffuse optical tomography (DOT) after the administration of indocyanine green (ICG) for contrast enhancement. The optical examination was performed concurrently with a magnetic resonance imaging (MRI) exam on patients scheduled for excisional biopsy or surgery so that accurate image coregistration and histopathological information of the suspicious lesions was available. The ICG-enhanced optical images coregistered accurately with Gadolinium-enhanced magnetic resonance images validating the ability of DOT to image breast tissue. In contrast to simple transillumination, we found that DOT provides for localization and quantification of exogenous tissue chromophore concentrations. Additionally our use of ICG, an albumin bound absorbing dye in plasma, demonstrates the potential to differentiate disease based on the quantified enhancement of suspicious lesions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MRI-DOT examination protocol.
Figure 2
Figure 2
Absorption increase of human breast attributable to ICG injection as a function of time and the correction applied.
Figure 3
Figure 3
Case I: Ductal carcinoma. (a) Functional sagittal MR image after Gd contrast enhancement passing through the center of the cancerous lesion. (b) Coronal DOT image, perpendicular to the plane of the MRI image in a, for the VOI indicated on a with the interrupted line box. (c) Functional MR coronal reslicing of the VOI with the same dimensions as b.
Figure 4
Figure 4
Case II: Fibroadenoma. (a) Functional sagittal MR image after Gd contrast enhancement passing through the fibroadenoma. (b) Coronal DOT image, perpendicular to the plane of the MRI image in a, for the VOI indicated on a with the interrupted line box. (c) Functional MR coronal reslicing of the VOI with the same dimensions as b.
Figure 5
Figure 5
Case III: No disease. (a) Functional sagittal MR image after Gd contrast enhancement passing through the middle plane of the breast. (b) Coronal DOT image, perpendicular to the plane of the MRI image in a, for the VOI indicated on a with the interrupted line box. (c) Functional MR coronal reslicing of the VOI with the same dimensions as b.

Similar articles

Cited by

References

    1. Arridge S R. Appl Opt. 1995;34:7395–7409. - PubMed
    1. O'Leary M A, Boas D A, Chance B, Yodh A G. Opt Lett. 1995;20:426–428. - PubMed
    1. Jiang H, Paulsen K D, Osterberg U L, Pogue B W, Patterson M S. J Opt Soc Am A. 1996;13:253–266.
    1. Gonatas C P, Ishii M, Leigh J S, Schotland J C. Phys Rev E. 1995;52:4361–4365. - PubMed
    1. Chang J H, Graber H L, Barbour R L. IEEE T Bio Med Eng. 1997;44:810–822. - PubMed

Publication types